Dual Guardian Cell System with External Trigger Kill Switch for Senolytic Therapy
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
This is a theoretical idea proposed by an independent young researcher from Tunisia. The concept involves engineering a therapeutic cell designed to hunt and eliminate senescent zombie cells. Attached to this main cell is a separate guardian cell that replicates alongside it every single time. The guardian cell has one single function — self destruct when it detects a specific externally injected weak acid or molecule. This solves the mutation problem in current iCasp9 kill switch systems because the kill switch is a completely separate cell. For control to fail both cells would need to mutate simultaneously which is statistically nearly impossible.The guardian cell system is a platform technology applicable to multiple diseases including cancer, autoimmune diseases, HIV, diabetes, and organ transplant rejection. The same dual cell framework applies universally. This is a novel combination of: Senolytic therapy Dual component suicide systems Guardian cell replication mechanism Date: March 24 2026 Author: Mehdi A, age 12, Tunisia
Fields of Study & Subjects
Telomeres
Telomerase
and Senescence
CRISPR and Genetic Engineering
Bacterial Cancer Therapy
Publication details
- Journal / source
- OSF Preprints (OSF Preprints)
- Publication date
- 15 July 2026
- Language
- EN
- Document type
- Preprint